Phase 1 Study of Anti-Glycation Agent GLY-230 in Healthy Subjects
This study has been completed.
Information provided by:
First received: October 15, 2007
Last updated: NA
Last verified: October 2007
History: No changes posted
To test the safety of GLY-230 and to evaluate how long drug stays in blood after taking it by mouth.
|Study Design:||Allocation: Randomized
Endpoint Classification: Pharmacokinetics Study
Intervention Model: Parallel Assignment
Masking: Open Label
|Official Title:||Phase 1 Study of Anti-Glycation Agent GLY-230|
Further study details as provided by Glycadia:
Contacts and Locations